Details

dr. Esther Croes

Position
arts-epidemioloog
Program
Drug Monitoring & Policy
Telephone
+31 (0)30 - 2959(230)
E-mail
Contact page
Esther  Croes

Expertise

Esther Croes has been trained as a medical doctor (cum laude) and genetic and clinical epidemiologist. Before she started at the Trimbos Institute, she has worked in surgery, wrote a PhD thesis on Creutzfeldt-Jakob disease and collaborated in a large study on common disorders in a genetically isolated population.

At the Department for Drug Monitoring & Policy at the Trimbos Institute she is project leader and co-worker in a wide range of projects. The main focus of her work is on the somatic consequences of substance use:

  • Tobacco control, ranging from implementation-support of cessation treatment, the pro’s and cons of the e-cigarette, education of health care professionals with training and summaries of scientific news, to scientific reviews of tobacco control policy measures.
  • Drug-related emergencies, based on a unique monitor in emergency departments, ambulance services, medical forensic departments and first aid stations at large events.
  • Viral hepatitis, from implementation projects on hepatitis treatment in addiction care to membership of the National Steering Committee on Viral Hepatitis and the Advisory Committee on hepatitis screening from the Dutch Health Council.

Esther Croes is member of the Reitox National Focal Point, has been a methodologist in a national medical ethical committee and the ethical committee at Trimbos, has amble experience in a diverse range of international projects and is (co-)author of many national and international publications, both scientific and grey literature.

Relevant links

ResearchGate

Pubmed

www.hepcverslaving.nl

www.drugsincidenten.nl

Broek, F. van & Croes, E. (2017). Zeggen alle tieners ja tegen mdma? Informatief, 23(2).

Chavannes, N.H., Meijer, E., Wind, L., Graaf, R.C. van de, Rietbergen, C., & Croes, E.A. (2017). Herziene richtlijn ‘Behandeling van tabaksverslaving en stoppen met roken ondersteuning’. Nederlands Tijdschrift voor Geneeskunde, 161, D1394.

Croes, E.A. (2017). De e-sigaret: een update . PIL(2), 35-37.

Croes, E.A., & Hopman, P. (2017). Tabaksontmoediging: we moeten harder dweilen. Tijdschrift voor gezondheidswetenschappen, 95(3), 95-96. doi:10.1007/s12508-017-0030-0

European Union HCV Collaborators (2017). Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. The Lancet Gastroenterology & Hepatology, 2(5), 325-336. doi:10.1016/S2468-1253(17)30045-6

Gee, A. de, croes, E., Putten, J. van, & Poel, A. van der (2017). Hepatitis C: alles uit de kast. Medisch Contact(mei), 21-23.

Helsper, C.W., Janssen, M.P., Essen, G.A. van, Croes, E.A., Veen, C. van der, Wit, A.G. de, & Wit, N.J.de (2017). Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands. The International Journal of Drug Policy(47), 117-125. doi:10.1016/j.drugpo.2017.07.022

Polaris Observatory HCV Collaborators (2017). Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The Lancet Gastroenterology & Hepatology, 2(3), 161-176. doi:10.1016/S2468-1253(16)30181-9

Reep-van den Bergh, C.M.M., Harteloh, P.P.M. & Croes, E.A. (2017). Doodsoorzaak nr. 1 bij jonge Nederlanders: de sigaret. Nederlands Tijdschrift voor Geneeskunde(41).

Wijers, C.H., Litsenburg, R.T. van, Hondebrink, L., Niesink, R.J., & Croes, E.A. (2017). Acute toxic effects related to 4-fluoroamphetamine. The Lancet, 389(10069), 600. doi:10.1016/S0140-6736(17)30281-7

Wits, E., Croes, E., Dijkstra, B. & Nattem, M. van (2017). Standaarden bieden houvast aan alle zorgverleners. Medisch Contact(mei), 18-20.

Croes, E. (2016). De waterpijp? Een ongezond product. Inspiratie vakblad voor longverpleegkundigen(december), 10-11.

Croes, E. A. (2015). Het belang van stoppen met roken. Nurse Academy GGZ , 3, 35-38.

Croes, E.A. (2015). De e-sigaret: een nieuwe bedreiging of een welkom hulpmiddel? De Praktijk(8), 15-18.

Croes, E., Niesink, R. (2015). De acute en chronische complicaties van cocaïnegebruik. Nurse Academy GGZ(1), 49-53.

Croes, E., & Weijde, W. ter (2015). De rokende patiënt en het belang van stoppen met roken. Nurse Academy(2), 59-63.

Croes, E., & Weijde, W. ter (2015). De rokende patiënt en het belang van stoppen met roken. Nursing, 21, 50-55.

Gane, E., Kershenobich, D., Seguin-Devaux, C., Kristian, P., Aho, I., Dalgard, O., Shestakova, I., ... Croes, E.A. (2015). Strategies to manage hepatitis C virus (HCV) infection disease burden: volume 2. Journal of Viral Hepatitis(January), 46-73. doi:10.1111/jvh.12352

Hatzakis, A., Chulanov, V., Gadano, A.C., Bergin, C., Ben-Ari, Z., Mossong, J., Schréter, I., ... Croes, E.A. (2015). The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm: volume 2. Journal of Viral Hepatitis(January), 26-45. doi:10.1111/jvh.12351

Niesink, R.J.M., Brunt, T.M., & Croes, E.A. (2015). Ecstasy: PMMA, MDMA en hooggedoseerde pillen. Verslaving : Tijdschrift over Verslavingsproblematiek, 11(2), 89-102. doi:10.1007/s12501-015-0020-3

Poel, A. van der, Lindt, S. van de, Laghaei, F., & Croes, E. (2015). Verbetering van de opsporing van hepatitis C in de verslavingszorg: Resultaten van doorbraakproject 2013-2014 . TSG(4), 129-131.

Saraswat, V., Norris, S., Knegt, R.J., Sanchez Avila, J.F., Sonderup, M., Zuckerman, E., Arkkila, P., ... Croes, E.A. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries: volume 2. Journal of Viral Hepatitis(January), 6-25. doi:10.1111/jvh.12350

Willemsen, M.A., Croes, E.A., Kotz, D., & Schayck, O.C.P. van (2015). [Electronic cigarettes: use, health risks, and effectiveness as a cessation method]. Nederlands Tijdschrift voor Geneeskunde, 159.

Willemse, S.B., Razavi-Shearer, D., Zuure, F,R,, Veldhuijzen, I.K., Croes, E.A., Meer, A.J. van der, & Santen, D.K. (2015). The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms. The Netherlands Journal of Medicine, 73(9), 417-431.

Croes, E.A. (2014). Vraagtekens rond de e-sigaret. Tijdschrift voor praktijkgerichte farmacotherapie, 4(1), 17-19.

Croes, E., Niesink, R. (2014). De elektronische sigaret: Panacee of weg ermee? Verslaving : Tijdschrift over Verslavingsproblematiek, 10(2), 74-82. doi:10.1007/s12501-014-0018-2

Niesink, R., Croes, E. (2014). Nicotine: Farmacologische en toxicologische aspecten. Verslaving : Tijdschrift over Verslavingsproblematiek, 10(1), 55-67. doi:10.1007/s12501-014-0007-5

Croes, E., Veen, C. van der (2013). Aandacht gevraagd voor hepatitis C in de verslavingszorg. Verslaving : Tijdschrift over Verslavingsproblematiek, 9(2), 34-42.

Niesink, R.J.M., Croes, E.A. (2012). Jongeren en drugs: van experiment tot problematisch (cannabis)gebruik. Praktische Pediatrie, 6(4), 202-206.

Croes, E. (2011). Somatiek in de verslavingsgeneeskunde. MGv: Maandblad Geestelijke volksgezondheid, 66(10), 772-775.

Sanchez-Juan, P., Bishop, M.T., Croes, E.A., Knight, R.S.G., Will, R.G., Duijn, C.M. van, Manson, J.C. (2011). A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt-Jakob disease. BMC Medical Genetics, 12(73). doi:10.1186/1471-2350-12-73

Schreuder, I., Sande, M.A.B. van der, Wit, M. de, Bongaerts, M., Boucher, C.A.B., Croes, E.A., Veen, M.G. van (2010). Seroprevalence of HIV, hepatitis b, and hepatitis C among opioid drug users on methadone treatment in the netherlands. Harm Reduction Journal, 26(7), 25-32.